Circumvent Pharmaceuticals, Inc.

CIK: 1855639DEIncorporated: 2015-08-24

Current Offering

$25,000
Target Amount
$250,000
Maximum Amount
2021-12-31
Deadline

Security Details

Type: Crowd SAFE
Price per share: $25,000
Shares offered: 25,000+

Offering Costs

Cash commission: 5%
A $10,000 setup fee, a cash commission equal to 5% of the gross proceeds of the offering and 2% of the securities sold.
Equity compensation: 0%
N/A

Financial Reports

Offering via Bioverge Portal, LLC

Offering History

As of 2021-07-12
Raising $25,000 -$250,000 via 25,000+ shares of crowd SAFE at $25,000 per share
Deadline: 2021-12-31
Filing date2021-07-12
Current employees4
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$1,740,529
Cash equi prior fiscal year$2,135,149
Cost goods sold most recent fiscal year$889,278
Cost goods sold prior fiscal year$630,538
Long term debt most recent fiscal year$3,335,152
Long term debt prior fiscal year$2,798,152
Net income most recent fiscal year-$888,189.60
Net income prior fiscal year-$629,632.01
Revenue most recent fiscal year$1,088
Revenue prior fiscal year$905.66
Short term debt most recent fiscal year$55,625
Short term debt prior fiscal year$0.00
Tax paid most recent fiscal year$3,818
Tax paid prior fiscal year$3,031
Total asset most recent fiscal year$1,740,529
Total asset prior fiscal year$2,135,149

Company Information

Corporation
DE
2015-08-24

Latest Metrics

Employees4
Total Assets$1,740,529
Cash on Hand$1,740,529
Revenues$1,088
Net Income-$888,189.60

Crowdfunding Portals

This company is raising funds through this portal